Zhejiang Hugeleaf Competitors and Similar CompaniesClear all

Zhejiang Hugeleaf's competitors and similar companies include AGP, Tianjin Pharmaceutical, Dong-E-E-Jiao and Zhejiang Huahai Pharmaceutical.

	Zhejiang Hugeleaf Zhejiang Hugeleaf is a manufacturer and distributor of medical products.	AGP AGP is a company that is a pharmaceutical manufacturer. I	Tianjin Pharmaceutical Tianjin Pharmaceutical is a manufacturer and distributor of Chinese medicine, western medicine, and healthcare products.	Dong-E-E-Jiao Dong-E-E-Jiao is a manufacturer and distributor of medicines, biological drugs, and health food products.	Zhejiang Huahai Pharmaceutical Zhejiang Huahai Pharmaceutical (浙江华海药业股份有限公司) is a pharmaceutical company that manufactures and distributes medicinal and health products.
Founding Date	Founding Date 1999	Founding Date N/A	Founding Date 1992	Founding Date 1952	Founding Date 1989
Type	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Manufacturing & Industrial distribution pharma	Tags Manufacturing & Industrial distribution pharma	Tags Manufacturing & Industrial distribution pharma	Tags Manufacturing & Industrial distribution pharma	Tags Manufacturing & Industrial distribution pharma
Locations	Locations HQ	Locations Karachi, PK HQ Karachi, PK Karachi, PK	Locations HQ	Locations Liaocheng, CN HQ	Locations Taizhou, CN HQ Hangzhou, CN Munich, DE Franklin, US
Employees	Employees N/A	Employees N/A	Employees N/A	Employees 4,095	Employees 9,065
Valuation ($)	Valuation ($) 982.3 m	Valuation ($) N/A	Valuation ($) 3.2 b	Valuation ($) 5.3 b	Valuation ($) 3.8 b
Financial
Revenue (est.)	Revenue (est.) ¥1.8b (FY, 2025)	Revenue (est.) ¥14.4b (FY, 2025)	Revenue (est.) ¥4.8b (FY, 2025)	Revenue (est.) ¥6.6b (FY, 2025)	Revenue (est.) ¥8.4b (FY, 2025)
Cost of goods	Cost of goods ¥1.7b (FY, 2025)	Cost of goods ¥10.9b (FY, 2025)	Cost of goods ¥1.3b (FY, 2025)	Cost of goods ¥1.8b (FY, 2025)	Cost of goods ¥3.4b (FY, 2025)
Gross profit	Gross profit ¥139.5m (FY, 2025)	Gross profit ¥3.6b (FY, 2025)	Gross profit ¥3.6b (FY, 2025)	Gross profit ¥4.8b (FY, 2025)	Gross profit ¥5.1b (FY, 2025)
Net income	Net income ¥200.9m (FY, 2025)	Net income ¥973.5m (FY, 2025)	Net income ¥2.1b (FY, 2025)	Net income ¥1.7b (FY, 2025)	Net income ¥227.3m (FY, 2025)